drugset / Trial / NCT01594671
Tranexamic Acid for Unilateral Total Knee Arthroplasty
RandomizedParallel-groupOpen-labelDiagnostic
Summary
Total knee arthroplasty is often associated with excessive postoperative bleeding due to increased fibrinolysis. Hence, the objective of the proposed of this multicentre study is to determine the peri-operative bleeding comparing the application of topical and intravenous tranexamic acid with the habitual surgical haemostasis.
Timeline
- Start
- 2012-02
- Primary completion
- 2012-10
- Completion
- 2012-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tranexamic Acid | Small molecule | 1000 mg | Intravenous |
Indications
No indication recorded.